Drug discovery research at University of Nottingham supported by SPT Labtech

SPT Labtech, global developer and manufacturer of high quality, robust and innovative automated laboratory equipment, is enabling a successful new venture at the University of Nottingham’s Centre for Biomolecular Science, with its comPOUND® sample storage system and comPILER® high throughput, tube-to-plate processing system.

1215TTPcomPILER_low res resized

The fully automated state-of-the-art facility for the Managed Chemical Compound Collection (MCCC) provides storage for more than 100,000 diverse drug-like small molecules for high throughput compound screening. The facility is key, not only to the University’s drug discovery research but also provides services to pharmaceutical and biotech industry partners, generating important growth potential for the University.

The comPOUND® modular system provides a compact and secure, fully automated storage and dispensing facility for chemical and biological compound libraries. Up to 100,000 1.4 mL tubes or 200,000 0.5 mL microtubes can be stored per unit in a temperature controlled, dry, inert, hermetically sealed environment; ensuring sample integrity. Sample storage in microtube format allows cherry picking of only the samples of interest and mitigates risks of sample degradation from unnecessary freeze/thaw cycles, inherent with plate-based systems.

1215TTPcomPOUND_low Res resized

Prof. Peter Fischer, Director, Centre for Biomolecular Sciences, University of Nottingham, commented, “Translational research is a key focus in the University, with a strong track record in pharmaceutical sciences. Worldwide pharmaceutical companies are turning to academic partners to support compound screening for drug R&D. The long-term vision is to provide a unique compound collection attractive to academic and pharma partners – especially SMEs without their own collections”.

“We were looking for an integrated compound storage and handling system that would increase throughput, maintain long-term compound integrity, improve reliability with complete inventory control and unattended operation”, he continued.

Simon Tullett, Product Manager for comPOUND and comPILER also commented “We are delighted to be supporting a venture such as the MCCC. Our systems readily integrated with the existing lab set-up and have been operational for a year”.

He continued, “With scope to integrate up to six comPOUND stores simultaneously with the comPILER platform, you can minimise your initial investment in capital equipment, yet still grow your library and your throughput when required”.

For more information please visit www.ttplabtech.com. Follow us on twitter @ttplabtech.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    SPT Labtech. (2020, January 21). Drug discovery research at University of Nottingham supported by SPT Labtech. News-Medical. Retrieved on April 18, 2024 from https://www.news-medical.net/news/20120803/Drug-discovery-research-at-University-of-Nottingham-supported-by-TTP-Labtech.aspx.

  • MLA

    SPT Labtech. "Drug discovery research at University of Nottingham supported by SPT Labtech". News-Medical. 18 April 2024. <https://www.news-medical.net/news/20120803/Drug-discovery-research-at-University-of-Nottingham-supported-by-TTP-Labtech.aspx>.

  • Chicago

    SPT Labtech. "Drug discovery research at University of Nottingham supported by SPT Labtech". News-Medical. https://www.news-medical.net/news/20120803/Drug-discovery-research-at-University-of-Nottingham-supported-by-TTP-Labtech.aspx. (accessed April 18, 2024).

  • Harvard

    SPT Labtech. 2020. Drug discovery research at University of Nottingham supported by SPT Labtech. News-Medical, viewed 18 April 2024, https://www.news-medical.net/news/20120803/Drug-discovery-research-at-University-of-Nottingham-supported-by-TTP-Labtech.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
SPT Labtech Empowers UK Genomics Community by Opening its Doors for the firefly® Roadshow